News | Artificial Intelligence | March 23, 2020

Vantage Galan 3T the First System in the MR Portfolio with Access to Advanced intelligent Clear-IQ Engine (AiCE)

Advanced intelligent Clear-IQ Engine (AiCE) is pending 510(k) clearance on the Aquilion ONE / PRISM Edition and Aquilion Prime SP CT systems, as well as the Vantage Galan 3T and Vantage Orian 1.5T MR systems

March 23, 2020 — Canon Medical Systems USA, Inc. has received 510(k) clearance on its Advanced intelligent Clear-IQ Engine (AiCE) for the Vantage Galan 3T magnetic resonance imaging (MR) system, further expanding access to its new Deep Learning Reconstruction (DLR) technology. This technology, which is also available across a majority of Canon Medical’s CT product portfolio, uses a deep learning algorithm to differentiate true MR signal from noise so that it can suppress noise while enhancing signal, forging a new frontier for MR image reconstruction.

AiCE was trained using vast amounts of high-quality image data, and features a deep learning neural network that can reduce noise and boost signal to quickly deliver sharp, clear and distinct images, further opening doors for advancements in MR imaging. Capabilities include:

  • High quality images: AiCE allows for the differentiation of true signal from noise through deep learning innovation to match the spatial resolution and low-noise properties of advanced scanning and reconstruction, while maintaining the true structure of the anatomy.
  • Seamless integration into routine practice: AiCE is the world’s first fully integrated deep learning reconstruction for MR, and is built directly into the scan protocols for seamless workflow.
  • Preferred AiCE MR image quality over non-AI reconstruction images: Following a blinded image comparison of AiCE DLR reconstructed images with images reconstructed with conventional methods without AiCE, physicians stated preference for AiCE images for clarity and resolution.

“AiCE utilizes a next generation approach to MR image reconstruction, further proving Canon Medical’s leadership and commitment to innovation in diagnostic imaging,” said Jonathan Furuyama, managing director, MR Business Unit, Canon Medical Systems USA, Inc. “With the expansion of this unique DLR method across modalities and into MR, we’re elevating diagnostic imaging capabilities for our customers by bringing the power of AI to routine imaging to provide more possibilities in improving patient care than ever before.”

For more information: www.us.medical.canon


Related Content

News | FDA

May 6, 2026 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time May 07, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

April 27 2026 — SimonMed, one of the nation’s largest independent outpatient imaging providers, has announced the ...

Time May 04, 2026
arrow
News | X-Ray

April 29, 2026 — Results from a new study* presented at the American Roentgen Ray Society’s (ARRS) 2026 annual meeting ...

Time April 29, 2026
arrow
News | Imaging Software Development

April 28, 2026 — Avatar Medical has been granted FDA 510(k) clearance for Avatar Medical Vision, its software platform ...

Time April 28, 2026
arrow
News | Cardiac Imaging

April 28, 2026 — Abbott has received U.S. Food and Drug Administration (FDA) clearance and CE Mark for its next ...

Time April 28, 2026
arrow
News | Artificial Intelligence

April 20, 2026 — DeepTek, provider of the Augmento platform and deepc, the company behind deepcOS, have introduced a ...

Time April 23, 2026
arrow
News | FDA

April 16, 2026 — Royal Philips has received U.S. Food and Drug Administration 510(k) clearance for the Philips Spectral ...

Time April 20, 2026
arrow
News | Radiology Imaging

April 7, 2026 — Onvida Health and Siemens Healthineers have entered a 10-year Value Partnership¹ designed to bring the ...

Time April 09, 2026
arrow
News | Computed Tomography (CT)

April 2, 2026 — GE HealthCare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for True ...

Time April 03, 2026
arrow
News | Ultrasound Imaging

March 30, 2026 — Butterfly Network, Inc. has received clearance from the U.S. Food and Drug Administration (FDA) for a ...

Time April 01, 2026
arrow
Subscribe Now